Cv bookman 9pt - Cleveland Clinic
|Present Position |Office Address: |
|Associate Staff (Faculty), Department of Bioethics |Department of Bioethics |
|Associate Staff, Transplant Center |Cleveland Clinic |
|Director, GCRC Research Subject Advocate Program |9500 Euclid Ave, Mailcode JJ-60 |
|Cleveland Clinic |Cleveland, Ohio 44195 |
|Cleveland Clinic Lerner College of Medicine |Phone: (216) 444-0204, (216) 312-4460 |
| |Fax: (216) 444-9275 |
| |Email: txbioethics@ |
Education
Monash University Faculty of Medicine, Ph.D. (Community Medicine & General Practice--Bioethics emphasis), 2002
University of California Los Angeles School of Medicine, Fellow (Biomed. & Res. Ethics), 1998-2000
Loma Linda University, M.A. (Biomedical & Clinical Ethics), 1998
Loma Linda University, B.S. (Health Science), 1989
Academic
Bioethicist, Associate Staff (Faculty), Cleveland Clinic, July 2002–present
Clinical Ethics Associate, Loma Linda University, Bioethics Center, January 2001-June 2002.
Ethics Fellow, University of California Los Angeles School of Medicine, 1998-2000.
Teaching Assistant, University of California Los Angeles School of Medicine, 1999-2000.
Administrative
Director, Cleveland Clinic General Clinical Research Center (GCRC) Research Subject Advocate Program, March 2003-present
Course Director, “Responsible Conduct in Research” (Cleveland Clinic Foundation Lerner Research Institute). 2005.
Course Director, “Ethics in Laboratory Research” (Cleveland Clinic Lerner College of Medicine). 2004 – present.
Course Director, “Bioethics” (ETHC0301), 3rd & 4th year medical student elective (Cleveland Clinic Lerner College of Medicine). 2003-present.
Coordinator, Required Research Ethics Course, “Responsible Conduct in Research (Medicine M261),” Univ. of Calif. Los Angeles School of Medicine, 1999-2000.
Industry
Quality Engineer II (coronary stents): Guidant Vascular Intervention (Temecula, CA), 1997-1998.
Staff Engineer II, Dept. Supervisor (custom surgical sets): Baxter/Allegiance (Ontario, CA), 1995-1997.
Sr. Quality Engineer (CABG devices): Sorin Biomedical (Irvine, CA), 1993-1995.
Lab Manager (endocrinology): Lab of Reproductive Medicine (Loma Linda, CA), 1992.
Quality Engineer (vascular grafts): IMPRA/BARD (Tempe, AZ), 1991.
Lab Technician/Research Assistant (pulmonary & endocrinology): Loma Linda University, 1987-1991.
Quality Control Chemist (serum diagnostics), AALTO Scientific (Escondido, CA): 1986.
Clinical (over 500 consultations conducted using single consult model)
Member, Ethics Consultation Service, Cleveland Clinic, July 2002 – present
Member, Heart Transplant Selection Committee, Cleveland Clinic, August 2002 – present
Member, Liver Transplant Selection Committee, Cleveland Clinic, July 2002 – present
Member, Living Liver Donor Advocate Team, Cleveland Clinic, January 2005 - present
Member, Ethics Consultation Service, Veterans Administration Medical Center (West Los Angeles, CA), 1999-2000.
Ethics Fellow, University of California Los Angeles School of Medicine, 1998-2000.
In-patient ethics consultation clinical training supervised by Robert Orr, M.D., Loma Linda University Medical Center, 1997-1998.
Committees
Cleveland Clinic General Clinical Research Center Executive Comm. (Cleveland, OH), 2003-present
Cleveland Clinic General Clinical Research Center Advisory Comm. (Cleveland, OH), 2003-present
Cleveland Clinic Research Compliance Committee (Cleveland, OH), 2003-2005
Cleveland Clinic Responsible Conduct in Research Committee, (Cleveland, OH), 2006
Cleveland Clinic Organ Donation Committee (Cleveland, OH), 2005-present
Cleveland Clinic Medical Student Education Council (Cleveland, OH), 2003-2004
Cleveland Clinic Intro to Clinical Medicine Curriculum Task Force (Cleveland, OH), 2003-present [Ethics Thread Leader]
Cleveland Clinic Pastoral Care Advisory Committee (Cleveland, OH), 2004-2005
Veterans Administration Medical Center Bioethics Committee (West Los Angeles, CA), 1999-2000
University of California Los Angeles Medical Center Ethics Committee, 1998-2000
The Endocrine Society Ethics Advisory Committee (Bethesda, MD), 1998-2001
Professional Activities
Invited Lectures & Media Activities
Interviewed by author Laura Greenwald for her book about face transplantation. February 2006.
City-Wide Ethics Discussion (Cleveland, OH): “Evaluating Potential Non-Directed Living Donors”, February 2006.
Interviewed by Cleveland Clinic Magazine regarding IRB use of bioethics consultation services for the face transplant project. December 2005.
Journal Interview, IRB Advisor, “IRBs Say There’s Too Much Work, Not Enough Help”, November 2005, pp 127-130.
Journal Interview, Berkeley Medical Journal, regarding the ethical issues associated with face transplantation. November 2005.
Interviewed by Associated Press for a story about the ethical issues associated with recruiting human subjects for medical research, October 2005.
Television Interview, Fox News (local), regarding privacy & public health surveillance of diabetics, July 2005.
Case Western Reserve University (Cleveland, OH): “Ethics in Clinical Research”, CRSP 401 lecture, July 2005.
Invited Lectures & Media Activities, continued…
Television Interview, CBS News (national), regarding use of drug BiDil by African Americans, June 2005.
Journal Interview, IRB Advisor, “Review Warning Letters to Prepare for Audits”, May 2005, pp 54-56.
City-Wide Ethics Discussion (Cleveland, OH): “Use of a Bioethicist in Evaluating Potential Liver Transplant Donors and Recipients”, March 2005.
The Cleveland Clinic (Cleveland, OH): “Ethical Issues in Clinical Trials”, Research Grand Rounds, October 2004.
Dobama Theatre (Cleveland, OH): “Response to ‘Domino Heart’: Ethical Issues in Transplantation”, November 2003.
Cleveland Clinic (Cleveland, OH): “The Complexities of Informed Consent”, Research Grand Rounds, October 2003.
Veterans Administration Medical Center (Cleveland, OH): “Geriatric Health Care Allocation in the Setting of High-Tech Medicine”, Geriatric Grand Rounds, April 2003.
Cleveland Clinic (Weston & Naples, FL): “’Competency’ and Informed Consent in Clinical Practice and Research”, Medical Grand Rounds, February 2003.
University of Akron, Department of Philosophy (Akron, OH): “The Ethical Complexities of the AbioCor TAH Clinical Trial”, November 2002.
Children’s Hospital of Orange County-Cypress College (Orange, CA): “Clinical Ethicists and the Ethics Consultation Process”, February 2002.
Cleveland Clinic (Cleveland, OH): “Ethical Complexities of Total Artificial Heart Technology: Clinical Research and Future Clinical Practice”, January 2002.
Loma Linda University Medical Center (Loma Linda, CA): “Ethical Complexities of Total Artificial Heart Technology”, Grand Rounds, November 2001.
La Sierra High School Science Academy (Riverside, CA): “Frontiers in Transplantation”, September 2001.
Radio Interview, 88.5FM (Atlanta, GA): “Ethics & the Total Artificial Heart”, July 2001.
Baxter, Hyland Division (Duarte, CA): “Topics in Bioethics”, September 2000.
University of California Irvine, Department of Surgery (Orange, CA): “Understanding Conflict of Interest”, July 2000.
Veterans Administration Medical Center (West Los Angeles, CA): “The Picture of the Patient”, January 2000.
Conference Presentations (Regional/National/International)
National Institutes of Health (NIH) General Clinical Research Center Annual Meeting (Washington DC): “Informed Consent: A Domain for the Research Subject Advocate”, March 2006.
American Heart Association Scientific Sessions 2005 (Dallas, TX): "Informed Consent for Destination Ventricular Assist Device Support”, November 2005.
American Heart Association Scientific Sessions 2005 (Dallas, TX): "End of Life Care for Patients with Ventricular Assist Device Support”, November 2005.
Conference Presentations (Regional/National/International), continued…
American Society for Bioethics and Humanities Annual Meeting (Washington DC): “Selecting HLA-Matched Embryos through PGD when a Sibling Needs a Solid Organ Transplant”, Kalfoglou A and Bramstedt KA, oral presentation, October 2005.
XVX European Conference on Philosophy of Medicine and Health Care (Barcelona, Spain): “When Microchip Implants do More than Drug Delivery: Blending, Blurring, and Bundling of Protected Health Information and Patient Monitoring”, August 2005.
11th Meeting of the International Liver Transplantation Society (Los Angeles, CA). “Regional Approach To Maximize Split Liver Graft Utilization: A Preliminary Report”, [poster presentation], July 2005.
National Institutes of Health (NIH) General Clinical Research Center Annual Meeting (Washington DC): “Opportunities for Research Subject Protection in Genetic Studies”, April 2005.
National Institutes of Health (NIH) General Clinical Research Center Annual Meeting (Washington DC): “A Strategy for Evaluating Data and Safety Monitoring Board Members and Charters”, April 2005.
Northern Ohio Lactation Consultant Association Meeting (Cleveland, OH): “Addressing the Ethical Complexities of Formula Discharge Packs”, April 2005.
Cleveland Ophthalmology Society Meeting, Legal and Ethical Issues in Ophthalmology (Independence, OH): “Topics in Ethics and Ophthalmology Research”, December 2004.
U.S. Dept. of Health and Human Services Office of Research Integrity Conference on Research Integrity (San Diego, CA): “A Study of Warning Letters Issued to Clinical Investigators by the FDA”, November 2004.
American Society for Stereotactic and Functional Neurosurgery meeting, Neuromodulation 2004: Defining the Future (Cleveland, OH): “Protecting Human Subjects: Psychogenic Dystonia as an Exclusion Criterion for Deep Brain Stimulation Trials”, [poster presentation], October 2004.
Thoratec, At the Heart of the Matter: Improving Clinical Outcomes for Patients with End-Stage Heart Failure (Hollywood, FL): “End of Life Care for Patients with VADs”, October 2004.
National Institutes of Health (NIH) General Clinical Research Center Annual Meeting (Chicago, IL): “Research Subject Advocacy and Litigation in Clinical Research”, April 2004.
American Epilepsy Society Annual Meeting (Boston, MA): “Now We Lay Them Down to Sleep: Ethical Issues with the use of Pharmacologic Coma for Adult Status Epilepticus”, [poster presentation], December 2003.
Heart Failure Summit VIII (Cleveland, OH): “Terminating Mechanical Cardiac Support”, October 2003.
Fifth Annual Cleveland Clinic Foundation-University Hospital Transplant Research Day (Cleveland, OH): “Shopping for a Transplant: When Non-compliant Patients Seek Wait Listing at Multiple Hospitals”, May 2003.
Conference Presentations (Regional/National/International), continued…
Annual Meeting of the Cleveland Consultation Liaison Society (Bratenahl, OH): “Shopping for a Transplant: The Dilemma of Multiple Listing and Non-compliant Patients”. Winner, “Best Presentation”-Mahmoud Parsa Award, May 2003.
Sixth Symposium World Artificial Organ, Immunology & Transplantation Society (Ottawa, Canada): “Informed Consent and the Total Artificial Heart”, August 2001.
Society of Geriatric Cardiology Annual Meeting (Anaheim, CA): “Concerns Against the use of Age-based Categorical Standards in Cardiac Health Care Decision-Making for the Elderly”, [poster presentation], April 2000.
First International Conference on Ethical Issues in Biomedical Engineering (Clemson, SC): “LVADs: an Ethical Analysis”, September 1997.
Conference Activities
Education Committee, NIH General Clinical Research Center Annual National Meeting (Chicago, IL), April 2004.
Grand Awards Judge (Medicine & Health Sciences), Intel International Science and Engineering Fair (Cleveland, OH), May 2003.
Program Committee & Session Chair, Clinical Ethics Consultation: First International Assessment Summit (Cleveland, OH), April 2003.
Consultation
Consultant, National Institutes of Health (Bethesda, MD). Grant reviewer. 2005-2006
Consultant, Israel Science Foundation (Jerusalem, Israel). Grant reviewer. 2005
Consultant, Thoratec (Pleasanton, CA). End of life care for patients with VADs. 2004
Consultant, US Food and Drug Administration Advisory Panels (Washington DC). Ethical issues in medical device clinical trial design, ethical issues in clinical practice and transplantation. 2003-present
Consultant, Austin & Repatriation Medical Centre (Heidelberg, Australia). Regarding creating a clinical ethics consultation service for the facility. 2002
Consultant, Loma Linda University (Loma Linda, CA). Office of Sponsored Research. Audit preparation, document review, human subjects policy and procedure manual completely overhauled. 2001
Consultant, The Endocrine Society (Bethesda, MD). Research ethics and the ethics of clinical practice of endocrinology. 1998-2001
Journal/Referee Service
Editorial Consultant, The Lancet (2005-2007)
Advisory Board, Plagiary (2006)
Manuscript Reviewer, ASAIO Journal (American Society of Artificial Internal Organs Journal)
Manuscript Reviewer, American Journal of Transplantation
Manuscript Reviewer, Journal of Heart and Lung Transplantation
Manuscript Reviewer, Journal of Medical Ethics
Grants
“Recruiter’s perceptions of ethical issues in genetic research”, NIH, 2005-2006. CGREAL Grant/E. Jeungst/Griffin MT, Cassano J, Bramstedt KA (co-investigator).
“Termination of ICDs and Pacemakers”, 2004-2006. Joint project with Mayo Clinic. Role: Co-investigator
“General Clinical Research Center”, NIH, 2003-2008 (~$2.5 mill/yr). Role: GCRC RSA Director
“Automatic Control of Cardiovascular Assist Devices”, NIH, 2003-2008 ($679,000). Role: Faculty Development Mentor
“Code of Professional Ethics”, The Endocrine Society, 1998-2001 ($25,000). Role: Co-investigator
“Responsible Conduct in Research”, University of California Los Angeles School of Medicine, 1999-2000 ($20,000). Role: Co-investigator.
“Endo-00: Understanding the Professional Norms of endocrine scientists and clinicians”, The Endocrine Society, 2000 ($5000). Role: PI
“Endo-99: Understanding the Professional Norms of endocrine scientists and clinicians”, The Endocrine Society, 1999 ($5000). Role: PI
Professional Organizations
Fellow, Royal Society of Medicine, 2006
Co-Chair, NATCO Ethics Committee, 2006
American Society for Bioethics and Humanities, 1998 - present
Society of Research Subject Advocates (SRSA), 2003-present
SRSA Research and Accomplishments Committee, 2005
Cleveland Consultation Liaison Society, 2003
American Society of Artificial Internal Organs (ASAIO), 2003-present
ASAIO Regulatory Affairs Committee, 2005
International Society for Heart and Lung Transplantation (ISHLT), 2003-present
ISHLT Council on Heart Failure and Transplant Medicine, 2003-present
ISHLT Council on Mechanical Circulatory Support, 2003-present
ISHLT Council on Xenotransplantation, 2003-present
ISHLT Council on Nursing and Social Sciences, 2003-present
American Geriatrics Society, 1999 – 2002
Society of Geriatric Cardiology (SGC), 1999 – 2002
SGC Public Policy Committee, 2001-2002
Publications
Peer-reviewed Articles
1. Bramstedt KA. When pharmacists refuse to dispense prescriptions. Lancet 2006;346:in press.
2. Bramstedt KA, Ford P. Protecting human subjects in neurosurgical trials: the challenge of psychogenic dystonia. Contemp Clin Trials 2006;27:in press.
3. Bramstedt KA. Ethical treatment when financial resources are limited. Endocrine News 2006;31:in press.
4. Bramstedt KA, Young JB. Use of the Internet by US heart transplant centers to promote transparency in the process of patient selection. Telemed J E Health 2006;12:in press.
Peer-reviewed Articles, continued
5. Bramstedt KA. Is it ethical to prioritize patients for organ allocation according to their values about organ donation? Prog Transpl 2006;16:in press.
6. Bramstedt KA. Transfusion contracts for Jehovah’s Witnesses receiving organ transplants: Ethical necessity or coercive pact? J Med Ethics 2006;32:193-195.
7. Bramstedt KA. Supporting organ transplantation in Non-Resident Aliens within limits. Ethics Med 2006;22:in press.
8. Bramstedt KA. Living liver donor mortality: where do we stand? Am J Gastroenterol 2006;101:in press.
9. Schneider PS, Bramstedt KA. When Psychiatry and Bioethics disagree about patient decision-making capacity (DMC). J Med Ethics 2006;32:90-93.
10. Bramstedt KA, Stowe J, Lemberg B. The dilemma of alcohol use by potential living liver donors. Prog Transplant 2006;16:24-27.
11. Bramstedt KA, Jabbour N. When alcohol abstinence criteria create ethical dilemmas for the liver transplant team. J Med Ethics 2006;32:in press.
12. Bramstedt KA, Florman S, Miller CM. Ethical challenges in live organ donation. Curr Opinion Organ Transpl 2005;10:340-344.
13. Bramstedt KA, Macauley R. A case of deception. Hastings Center Rep 2005;35:13-14.
14. Bramstedt KA, Schneider PS. Saying ‘good-bye’: Ethical issues in the stewardship of bed spaces. J Clin Ethics 2005;16:167-172.
15. Bramstedt KA, Nash P. When death is the outcome of informed refusal: the dilemma of rejecting ventricular assist device therapy. J Heart Lung Transpl 2005;24: 229-230.
16. Bramstedt KA. Bioethicists: Practitioners of applied philosophy. Philosoph Practice 2005;1:77-81.
17. Bramstedt KA. When microchip implants do more than drug delivery: Blending, blurring, and bundling of protected health information and patient monitoring. Technol Health Care 2005;13:193-198.
18. Bramstedt KA, Molner M, Carlson K, Bilyeau, S. When families complicate patient care: guidelines for handling resultant ethical dilemmas. MEDSURG Nursing 2005;14: 122-125.
19. Jabbour N, Gagandeep S, Bramstedt KA, et al. To do or not to do living donor hepatectomy in Jehovah’s Witnesses: Single institution experience of the first 13 resections. Am J Transplantation 2005;5:1141-1145.
20. Bramstedt KA. Surrogate consent for live organ donation. (Letter) JAMA 2004;291:2077-2078.
21. Bramstedt KA. A study of warning letters issued to clinical investigators by the US Food and Drug Administration (FDA). Clin Invest Med 2004;27:129-134.
22. Bramstedt KA. A guide to informed consent for clinician-investigators. Cleve Clin J Med 2004;71:907-910.
23. Bramstedt KA, Kassimatis K. A study of warning letters issued to Institutional Review Boards by the US Food and Drug Administration. Clin Invest Med 2004;27:316-323.
24. Bramstedt KA. When names make claims: Ethical issues in medical device marketing. Ethics Med 2004;20:47-57.
25. Bramstedt KA, Morris H, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav 2004;5:752-755.
26. Bramstedt KA, Stowe J, Kotz M. Shopping for a transplant: When non-compliant patients seek wait listing at multiple hospitals. Prog Transplant 2004;14:217-221.
Peer-reviewed Articles, continued…
27. Bramstedt KA. Elective inactivation of total artificial heart technology in non-futile situations: inpatients, outpatients, and research subjects. Death Studies 2004;28:423-433.
28. Bramstedt KA, Arroliga A. On the dilemma of refusal of life-saving therapy. Chest 2004;125:630-633.
29. Blixen C, Bramstedt KA, Hammel J, Tilley B. A pilot study of health education via a nurse-run telephone self-management program for elderly people with osteoarthritis. J Telemed Telecare 2004;9:44-49.
30. Bramstedt KA. When value and meaning become monetary rather than moral: issues in geriatric health care allocation. Ethics Law Aging Rev 2003;9:143-149.
31. Bramstedt KA. Questioning the decision-making capacity of surrogates. Int Med J 2003;33:256-259.
32. Bramstedt KA. Research subject advocates: To whom are they loyal. Clin Invest Med 2003;26:64-69.
33. Bramstedt KA. Using animals in medical research: Are there ethical concerns and biblical parameters on such use? Dialogue 2003;15:24-25.
34. Bramstedt KA. Contemplating total artificial heart inactivation in cases of futility. Death Studies 2003;27:295-304.
35. Bramstedt KA. Aortic valve replacement in the elderly: frequently indicated yet frequently denied. Gerontology 2003;49:46-49.
36. Bramstedt KA. Replying to Veatch’s concerns: Special moral problems with total artificial heart inactivation. Death Studies 2003;27:317-320.
37. Bramstedt KA. Patient productivity as a value and a variable in geriatric health care allocation. Cambridge Quart Healthcare Ethics 2002;11:94-96.
38. Bramstedt KA, Simeon DJ. The challenges of responding to ‘high-tech’ cardiac implant patients in crisis. Prehosp Emerg Care 2002;6:425-432.
39. Bramstedt KA. Failure Mode and Effects Analysis (FMEA) as an informed consent tool for investigational cardiothoracic devices. ASAIO J 2002;48:293-296.
40. Bramstedt KA. Left ventricular assist devices and the slippery slope of ageism. Intl J Cardiol 2001;81:201-203.
41. Bramstedt KA. Ethical issues associated with the determination of patient selection criteria for total artificial heart technology. Cardiovasc Eng 2001;6:258-261.
42. Bramstedt KA. Informed consent documentation for total artificial heart technology. J Artificial Organs 2001;4:273-277. Bramstedt KA.
43. Bramstedt KA, Wenger NS. When the withdrawal of life sustaining care does more than ‘allow death to take its course’: the dilemma of left ventricular assist devices. J Heart Lung Transpl 2001;20:544-548.
44. Bramstedt KA. The use of advance directives and DNR orders in decision-making regarding the inactivation of implantable cardioverter-defibrillators in terminal patients. Cardiovasc Rev Rep 2001;21:175-176.
45. Bramstedt KA. Ethics for scientists: a call for stewardship. Dialogue 2001;13:28-29.
46. Bramstedt KA. Why an alternate recipient list for heart transplantation is not a form of ageism. New Zeal Bioethics J 2001;2:27-32.
47. Korenman SG, Bach M, Bramstedt KA, et al. Code of ethics of the Endocrine Society. Endocrinology 2001;142:3701-3714.
48. Bramstedt KA. Scientific breakthroughs: cause or cure of the aging ‘problem’. Gerontology 2001;47:52-54.
Peer-reviewed Articles, continued…
49. Bramstedt KA. Age-based health care allocation as a wedge separating the person from the patient and commodifying medicine. Rev Clin Gerontol 2001;11:185-188.
50. Bramstedt KA. Resisting the blame game: visualizing the high cost of dying and accepting the duty of technology stewardship for all patient populations. A review. Arch Gerontol Geriatr 2001;33:53-59.
51. Korenman SG, Bramstedt KA. Your spouse/partner gets a skin infection and needs antibiotics—is it ethical for you to prescribe them? West J Med 2000;173:364.
52. Bramstedt KA. Arguments for the ethical permissibility of transgenic xenografting. Gene Therapy 2000;7:633-634.
53. Bramstedt KA. Left ventricular assist devices: an ethical analysis. Sci Eng Ethics 1999;5:89-98.
54. Bramstedt KA. Ethics and the clinical utility of animal organs. Trends Biotech 1999;17:428-429.
Abstracts
1. Miller C, Aucejo F, Fayek S, Winans C, Bramstedt K, et al. Regional Approach To Maximize Split Liver Graft Utilization: A Preliminary Report. Liver Transpl 2005;11:C78.
2. Bramstedt KA, Morris H, Serje A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsia 2003;44 (Suppl 9):121.
3. Bramstedt KA, Kendall K. Proposed role of a bioethicist in P.A.C.T. (Psychosocial Assessment of Candidates for Transplantation) scoring. ASAIO J 2003;49:141.
4. Bramstedt KA. Development of a clinical trial participant handbook for total artificial heart recipients. Cardiovasc Eng 2001;6:24.
5. Bramstedt KA. Concerns against the use of age-based categorical standards in cardiac health care decision-making for the elderly. Am J Geriatr Cardiol 2000;9:112.
6. Winslow GR, Bramstedt KA. Ventricular assist devices and the misguided ethics of rescue. Crit Rev Biomed Eng 1997;25:106-108.
Book Chapters
1. Bramstedt KA. 2006. Ethical Issues in Cardiothoracic Medicine. In A Combined Medical and Surgical Approach to Heart Failure, ed S Korn. Armonk, NY: Futura: in press.
2. Bramstedt KA and Korenman SG. 2001. Collaborative Science. In Responsible Conduct of Research: An Introductory Guide, ed. M Kalichman: 69-75. Washington DC: Office of Research Integrity.
3. Bramstedt KA and Korenman SG. 2001. Research Misconduct. In Responsible Conduct of Research: An Introductory Guide, ed. M Kalichman: 86-95. Washington DC: Office of Research Integrity.
Dissertation
Bramstedt, Katrina A. 2002. Formulating a Philosophy of Just Care for the Geriatric Population Amid the Opportunities of Modern Medicine. Melbourne, Australia: Monash University, 242pp.
Awards
Cleveland Clinic Bernard A. Loeschen Pastoral Care Award, 2005 (teaching award).
Education/Teaching Activities
1. Co-faculty, “Introduction to Clinical Research” (Cleveland Clinic/MPH 620 Cleveland State University). 2002-present. This course includes the following: how to look for research funding, grantwriting, writing protocols and consent/assent forms, biostatistical concerns, institutional review boards, ethical issues with genetic research and placebos. I teach the session on consent, genetics and placebos.
2. Co-faculty, “Introduction to Clinical Medicine” (Cleveland Clinic Lerner College of Medicine). 2003- present. I co-developed this course which includes professionalism and clinical ethics.
3. Faculty & Course Director, “Ethics in Laboratory Research” (Cleveland Clinic Lerner College of Medicine). 2004 – present. This is a 2hr workshop on ethics and laboratory science (good research practice, collegiality, authorship, data integrity, research misconduct, whistleblowing). I created and teach this 50-minute lecture and 60-minute discussion of 3 ethics cases for Year One medical students.
4. Faculty & Course Director, “Responsible Conduct in Research” (Cleveland Clinic). 2005. This is a 2hr workshop on ethics and laboratory science (good research practice, collegiality, authorship, mentoring, data integrity, research misconduct, whistleblowing, and research with animals). I created and teach this 50-minute lecture and 60-minute discussion of 3 ethics cases. I have also created an on-line version of this course.
5. Faculty & Course Director, “Responsible Conduct in Research for Animal Technicians” (Cleveland Clinic Lerner Research Institute). 2006. A variation of the above course, this is a 2hr workshop on ethics specifically geared toward animal technicians who work in the vivarium. I created and teach this 50-minute lecture and 60-minute discussion of 3 ethics cases.
6. Faculty & Course Director, “Bioethics” (ETHC0301), 3rd & 4th year medical student elective (Cleveland Clinic Lerner College of Medicine). 2003-present. I re-designed this elective in 2004 to include a research ethics rotation.
7. Staff, resident, post-doc, & allied health bioethics education, Cleveland Clinic. 2002-present
8. Biomedical Engineering bioethics education, Cleveland Clinic. 2002-present
9. Faculty & Course Director, “Bioethics for Social Workers”, CEU course, Cleveland Clinic. 2003-present. I created this seminar and teach it yearly to satisfy State licensing requirements for Social Workers.
Education/Teaching Activities, continued…
10. Faculty & Course Director, “Bioethics for Chaplains”, CPE course, Cleveland Clinic. 2003-present. I created this 5-week course and teach it yearly as part of national Clinical Pastoral Education Association program.
11. Faculty & Course Director, “Research Subject Advocate Workshops”. 2002 – present. One hour workshops for research nurses, coordinators and clinical investigators on various topics such as adverse event reporting, informed consent, study auditing, research subject protections.
12. Patient education: The Cleveland Clinic Heart Transplant Evaluation Process (available at )
13. Research subject educational brochure, “Clinical Research: What is it All About?” (Adult and pediatric versions of this brochure are available).
14. Loma Linda University Manual of Standard Operating Procedures for Studies in Human Subjects. Halstead LG and Bramstedt KA, 2001. (Separate annotated version, Bramstedt KA, 2001).
15. Total Artificial Heart Human Clinical Trial Protocol—Informed Consent, Subject Selection Criteria, Participant Handbook, Engineering Issues. Bramstedt KA, 2000
16. West Los Angeles Veterans Administration Medical Center Ethics Committee Training Handbook. Schneider PL, Bramstedt KA, 2000
17. Course development and co-faculty, “Responsible Conduct in Research” (Medicine M261). UCLA School of Medicine graduate/post-graduate research ethics: 1999, 2000. This is a 5-week course (five, 2 hr- sessions) covering the following topics: research with animals, human subjects research, misconduct, professionalism, and recording and reporting of data.
18. Course development and co-faculty, “Ethics for Scientists” (RELE 525). Loma Linda University graduate research ethics: 1998. This is a 10-week course covering general ethical issues in basic science and clinical research, including hot topics in research.
Trainees
Graduate Students
Alexander Curtis-Fall 2004
PhD Candidate, Bowling Green University Department of Philosophy
(CCF research rotation-PHIL791): general bioethics rotation
Jenny Sproul-Swindell-winter & spring 2004
PhD Candidate, Bowling Green University Department of Philosophy
(CCF research rotation-PHIL791) “A Review of United States’ Advance Directive Templates With Regard to Life-Sustaining Interventions”
Jason Gatliff- fall & winter 2003
PhD Candidate, Bowling Green University Department of Philosophy
(CCF research rotation-PHIL791) continuation of dissertation research
Katherine Ohnsorge- winter 2003
PhD Candidate, Institut fur Angewandete Ethik und Medizinethik, Basel
CCF Bioethics internship
Medical Students
Sherwin Yee-summer 2005
2nd year medical student, Cleveland Clinic Lerner College of Medicine
Patient selection criteria for septal defect surgery
Kate Conway-winter 2005
4th year medical student, Wright State University
Shadowed bioethics consultations
Samuel J. Youssef –winter 2004
5th year medical student, Kigezi International School of Medicine, UK
“Attaining Grace: Vitalism and Baby ‘M’”
Craig Eldridge-winter 2003
4th year medical student, Ohio State University
“Scientific, Economic, and Ethical Aspects of Umbilical Cord Blood Transplantation and Banking”
Trainees, continued…
Dan Valentino-summer 2003
4th year medical student, Ohio State University
Shadowed bioethics consultations, no research project.
Undergraduate Students
Evan Topal-summer 2004
3rd year Bioethics major, University of Virginia
mini-internship
Work in Progress
Young JB, Bramstedt KA. Hsich E. The dynamics and deliberations of transplant selection committees: A proposal.
Goldfarb J, Weise KL, Bramstedt KA. The Cleveland Clinic approach to research with children.
Bramstedt KA, Chalfant A, Wright C. Emergency consultation in the setting of transplant medicine: Dilemmas for Social Workers and Bioethicists.
O’Hara JF, Bramstedt KA, Flechner S, et al. Ethical and anesthetic management of recipient co-morbidity for living kidney donor transplantation.
Book chapter: Bramstedt KA, End of Life Care. IN: Supportive Care for Heart Failure. Oxford University Press. 2007
ασασασσασασα
March 16, 2006
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- georgia baptist college of nursing mercer university
- home hca healthcare
- principlism or narrative ethics
- national ethics teleconference ethical considerations
- cnl ethics course planning draft
- national ethics teleconference unsafe discharge us
- cv bookman 9pt cleveland clinic
- the ethical dilemma of advance directives
- chapter one nursing science and the foundation of
- philosophy and its influence on psychiatric nursing
Related searches
- cleveland clinic hypertrophic cardiomyopathy
- cleveland clinic hcm
- cleveland clinic dermatologist
- cleveland clinic general surgery
- cleveland clinic heart attack symptoms
- cleveland clinic mental health services
- cleveland clinic labs near me
- cleveland clinic spine doctors
- cleveland clinic spine specialist
- cleveland clinic back doctor
- cleveland clinic spine center doctors
- cleveland clinic spine center cleveland